Calcipotriene, Betamethasone Dipropionate
Calcipotriene, Betamethasone Dipropionate is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Calcipotriene and Betamethasone Dipropionate. Available dosage form: ointment.
Drug details
- Generic Name
- Calcipotriene, Betamethasone Dipropionate
- Brand Names
- Calcipotriene and Betamethasone Dipropionate
- Application Number
- ANDA200174
- Sponsor
- Padagis Israel Pharmaceuticals Ltd
- NDC Codes
- 4
- Dosage Forms
- OINTMENT
- Routes
- TOPICAL
- Active Ingredients
- CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE
Indications and Usage
1 INDICATIONS AND USAGE Calcipotriene and Betamethasone Dipropionate Ointment is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. Calcipotriene and Betamethasone Dipropionate Ointment is a vitamin D analogue and corticosteroid combination product indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. ( 1 )